Pfizer CEO: Omicron-specific COVID vaccine in progress



Pfizer Inc. CEO Albert Bourla said on Wednesday that the company is developing an Omicron-specific COVID vaccine.

Although final approval decisions are up to US regulators, “we are prepared for that,…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento